Delek US Holdings' Fifty-Two Quarter Distribution Streak Now Depends on One Earnings Report

Delek US Holdings (NYSE: DK) reports first-quarter 2026 earnings before the market opens on April 29, with analysts expecting a loss of $1.52 per share—a significant improvement from the prior-year quarter's loss of $2.32. The central question for investors: can the independent refiner demonstrate sustained progress on its Enterprise Optimization Plan and margin recovery amid volatile refining conditions, or will operational headwinds from the Big Spring turnaround and elevated costs overshadow the company's cost-cutting achievements?

Part 1: Earnings Preview

Delek US Holdings is an independent downstream energy company operating petroleum refining, logistics, and renewable fuels assets, with refineries in Texas, Arkansas, and Louisiana totaling 302,000 barrels per day of combined nameplate capacity. The company also controls approximately 63.3% of Delek Logistics Partners (NYSE: DKL), a midstream MLP focused on Permian Basin infrastructure.

Delek reports first-quarter 2026 results before the market opens on April 29. The consensus estimate calls for a loss of $1.52 per share on revenues of $2.1 billion. In the most recently reported quarter (Q4 2025), Delek posted adjusted earnings of $0.44 per share, beating expectations by 276% and marking a sharp turnaround from prior quarters. Compared to the same quarter last year (Q1 2025), when the company reported a loss of $2.32 per share, the current estimate implies 34.5% year-over-year improvement—though still reflecting a loss as the company navigates refinery downtime and margin pressures.

Three key themes define this earnings story:

Enterprise Optimization Plan Execution: Delek has been aggressively pursuing cost reductions and operational improvements, targeting approximately $200 million in annual run-rate cash flow improvements. Investors will scrutinize whether the company can demonstrate continued progress on this initiative, particularly after recognizing roughly $50 million of improvements in Q4 2025. The restructuring of the Inventory Intermediation Agreement, expected to generate at least $40 million in incremental free cash flow, represents another critical milestone in the company's transformation.

Big Spring Refinery Turnaround Impact: A planned turnaround at the Big Spring refinery is expected to significantly reduce throughput during the quarter, weighing heavily on refining margins and overall system utilization. Operating expenses are projected to rise due to preparations for winter storm disruptions, while interest costs remain elevated. This temporary operational headwind will test whether Delek's optimization efforts can offset reduced production volumes.

Refining Margin Environment and Regulatory Relief: The refining margin landscape remains volatile, though Delek has benefited from small refinery exemptions (SREs) under renewable fuel standards, which reduced costs by $356.1 million in 2025. Analysts will watch closely for commentary on crack spreads, feedstock costs, and whether regulatory relief continues to provide meaningful support. The company's ability to capture margin improvements through product optimization and wholesale marketing strength will be critical.

Analysts heading into the release emphasize cautious optimism. Zacks Investment Research notes that while Delek's earnings beat expectations in three of the trailing four quarters with an average surprise of 189%, the first-quarter estimate has been revised downward by 22.6% in the past seven days, reflecting concerns about turnaround impacts and margin pressure. However, several firms have upgraded their outlook: Goldman Sachs recently raised Delek from neutral to buy with a $55 price target, while Wells Fargo increased its target from $54 to $59, citing confidence in the optimization plan's execution and improving free cash flow generation.

Part 2: Historical Earnings Performance

Delek US has demonstrated a pattern of significant earnings volatility with a recent trend toward positive surprises. Over the past four quarters, the company beat estimates in three instances and missed once, with surprise magnitudes ranging from modest to extraordinary.

The most striking pattern emerged in the second half of 2025. In Q3 2025, Delek reported $1.52 per share against an estimate of $0.28, delivering a massive 442.86% surprise. This was followed by Q4 2025, where the company posted $0.44 per share versus expectations of a $0.25 loss, representing a 276% beat. These back-to-back outperformances suggest the Enterprise Optimization Plan began delivering tangible results in the latter half of the year.

Earlier in 2025, results were more mixed but still showed improvement. Q2 2025 produced a loss of $0.56 per share compared to the estimated loss of $0.92, a 39.13% positive surprise. However, Q1 2025 saw a slight miss, with a reported loss of $2.32 per share versus the $2.27 estimate, a -2.20% variance. The progression from significant losses in early 2025 to profitability by year-end illustrates the company's operational turnaround, though the upcoming quarter's planned turnaround activity may temporarily disrupt this positive momentum.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Delek US typically reports earnings before the market opens, meaning Day 0 represents the first full trading session where investors react to results, while Day +1 captures follow-through momentum.

Historical price behavior around Delek's earnings releases shows substantial volatility, with an average absolute Day 0 move of 4.96% and Day +1 move of 4.38%. The stock has exhibited a slight positive bias on earnings day, though reactions vary considerably based on result quality.

The most recent release (February 2026) saw a 4.76% gain on Day 0 with a trading range of 10.84%, followed by an 8.48% surge on Day +1, reflecting strong investor enthusiasm for the Q4 beat. Similarly, the November 2025 report triggered a 5.66% Day 0 jump with a 14.03% intraday range—the widest in the dataset—though Day +1 follow-through was muted at just 0.17%.

Not all reactions have been positive. The August 2025 release produced an -11.00% Day 0 decline with a 16.52% range, the largest negative reaction in recent history, though the stock recovered with a 4.08% gain the following day. Earlier releases in 2025 and 2024 showed more modest Day 0 reactions (often under 1%), but frequently delivered significant Day +1 moves exceeding 7-8%, suggesting investors often needed time to digest results and management commentary before establishing conviction.

Part 2.2: Options Market Expected Move

The options market is pricing an expected move of 10.77% through the May 15 expiration, significantly higher than the historical average Day 0 move of 4.96% and even exceeding the average Day 0 intraday range of 10.31%. This elevated implied volatility of 72.17% suggests options traders are anticipating a more dramatic reaction than typical, likely reflecting uncertainty around the Big Spring turnaround impact and whether cost optimization can offset operational headwinds.

Part 3: What Analysts Are Saying

Analyst sentiment on Delek US has improved recently, with the consensus shifting more bullish heading into earnings. The stock currently carries an average recommendation of 3.62 (between Hold and Buy), with 4 Strong Buy ratings, 1 Moderate Buy, 7 Holds, and 1 Moderate Sell among 13 analysts covering the stock. This represents a notable upgrade from one month ago, when the average recommendation stood at 3.43, with only 3 Strong Buys and 9 Holds.

The mean price target of $49.38 implies approximately 20% upside from the current price of $41.04, with estimates ranging from a low of $34.00 to a high of $63.00. This wide target range reflects divergent views on how quickly Delek can realize the benefits of its optimization initiatives and navigate near-term operational challenges. The high-end target of $63 suggests some analysts see substantial value if the company successfully executes its turnaround strategy and refining margins improve.

The recent sentiment improvement appears driven by growing confidence in Delek's Enterprise Optimization Plan and the economic separation from Delek Logistics. Goldman Sachs' upgrade to Buy and Wells Fargo's increased price target to $59 signal that leading analysts believe the company's cost-cutting efforts and improved capital allocation will drive meaningful free cash flow generation despite near-term headwinds. However, the persistence of 7 Hold ratings indicates many analysts prefer to see sustained execution before adopting a more aggressive stance, particularly given the upcoming Big Spring turnaround and ongoing margin volatility in the refining sector.

Part 4: Technical Picture

Delek US enters earnings with a 72% Buy signal from Barchart's Technical Opinion, representing a notable strengthening from 56% Buy one week ago and down from 100% Buy one month ago. This recent moderation suggests some near-term consolidation after a strong run, though the overall technical posture remains constructive.

Timeframe Analysis:

• Short-term (50% Buy): Moderate buy signal indicates near-term momentum has cooled somewhat, suggesting potential consolidation or digestion of recent gains ahead of the earnings catalyst
• Medium-term (100% Buy): Strong buy signal across the intermediate timeframe reflects solid underlying momentum and positive trend structure over the past several weeks
• Long-term (100% Buy): Strong buy signal in the longer-term view indicates the stock has established a sustained uptrend, with the 100-day and 200-day moving averages providing support

Trend Characteristics: The technical environment shows Average strength with a Strengthening direction, suggesting momentum is building gradually rather than exhibiting explosive or exhausted characteristics—a relatively neutral setup heading into a potentially volatile earnings event.

The stock is currently trading at $41.04, positioned above its 5-day ($40.08), 10-day ($39.80), and 50-day ($41.02) moving averages, indicating short-term strength. However, the price sits below the 20-day moving average of $41.42, suggesting some recent pullback from local highs.

The longer-term trend remains firmly positive, with DK trading well above both its 100-day ($36.18) and 200-day ($33.63) moving averages, confirming the stock has established higher ground over the past several months. The clustering of shorter-term moving averages near current price levels around $40-41 suggests this zone may act as a pivot point for the post-earnings reaction. The technical setup is moderately supportive heading into the release—the stock has room to move in either direction without immediately challenging major support or resistance levels, though the strengthening momentum and improved medium- to long-term signals provide a constructive backdrop if results and guidance can meet or exceed expectations.